Establishment and characterization of a patient-derived solitary fibrous tumor/hemangiopericytoma cell line model

Author:

Lee Jing Yi,Guan Peiyong,Lim Abner Herbert,Guo Zexi,Li Zhimei,Kok Jessica Sook Ting,Lee Elizabeth Chun Yong,Lim Boon Yee,Kannan Bavani,Loh Jui Wan,Ng Cedric Chuan-Young,Lim Kah Suan,Teh Bin Tean,Ko Tun Kiat,Chan Jason YongshengORCID

Funder

National Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Reference45 articles.

1. Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, Iyer MK, Roychowdhury S, Siddiqui J, Pienta KJ, Kunju LP, Talpaz M, Mosquera JM, Singer S, Schuetze SM, Antonescu CR, Chinnaiyan AM. Identification of recurrent NAB2–STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45(2):180–5. https://doi.org/10.1038/ng.2509.

2. Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M. Whole-exome sequencing identifies a recurrent NAB2–STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013;45(2):131–2. https://doi.org/10.1038/ng.2522.

3. Nonaka H, Kandori S, Nitta S, Shiga M, Nagumo Y, Kimura T, Kawahara T, Negoro H, Hoshi A, Kojima T, Kawai K, Mathis BJ, Tamura T, Sato TA, Yamato M, Noguchi M, Nishiyama H. Case Report: Molecular characterization of aggressive malignant retroperitoneal solitary fibrous tumor: A case study. Front Oncol. 2021;11: 736969. https://doi.org/10.3389/fonc.2021.736969.

4. Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K. Clinical and molecular implications of NAB2–STAT6 fusion variants in solitary fibrous tumour. Pathology. 2021;53(6):713–9. https://doi.org/10.1016/j.pathol.2020.11.010.

5. Tai HC, Chuang IC, Chen TC, Li CF, Huang SC, Kao YC, Lin PC, Tsai JW, Lan J, Yu SC, Yen SL, Jung SM, Liao KC, Fang FM, Huang HY. NAB2–STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors. Mod Pathol. 2015;28(10):1324–35. https://doi.org/10.1038/modpathol.2015.90.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3